Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496453 · ClinicalTrials.gov registry record · NA
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04496453: Completed NA study, sponsored by Duke University.
NCT04496453 is a NA study that has completed, run by Duke University. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04496453, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and evaluate a tool designed to help parents make decisions about childhood vaccines.
Primary Outcome
Study specific questionnaire comprised of 10 True or False questions. Knowledge was measured on a score of 0-10, where a higher score indicates a greater level of knowledge. Outcome reports on the difference in the knowledge score measure pre- and post- exposure to intervention.
Interventions
- OTHER Childhood vaccination decision support tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2022-03-24 |
| Phase | NA |
What the finished NCT04496453 record still lists
NCT04496453 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Childhood vaccination decision support tool is the first listed.
NCT04496453 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04496453 about?
NCT04496453 is a clinical study titled "Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations". The purpose of this study is to develop and evaluate a tool designed to help parents make decisions about childhood vaccines.
What is the current status of trial NCT04496453?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2020-12-14. Estimated completion is 2022-03-24.
What interventions are being tested in trial NCT04496453?
The interventions under investigation include: Childhood vaccination decision support tool (OTHER).
Who is sponsoring clinical trial NCT04496453?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04496453's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI